• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

融合驱动的儿童肉瘤细胞系的基因组和表型稳定性

Genomic and phenotypic stability of fusion-driven pediatric sarcoma cell lines.

作者信息

Kasan Merve, Geyer Florian H, Siebenlist Jana, Sill Martin, Öllinger Rupert, Faehling Tobias, de Álava Enrique, Surdez Didier, Dirksen Uta, Oehme Ina, Scotlandi Katia, Delattre Olivier, Müller-Nurasyid Martina, Rad Roland, Strauch Konstantin, Grünewald Thomas G P, Cidre-Aranaz Florencia

机构信息

Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.

Division of Translational Pediatric Sarcoma Research (B410), German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.

出版信息

Nat Commun. 2025 Jan 3;16(1):380. doi: 10.1038/s41467-024-55340-5.

DOI:
10.1038/s41467-024-55340-5
PMID:39753532
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11699042/
Abstract

Human cancer cell lines are the mainstay of cancer research. Recent reports showed that highly mutated adult carcinoma cell lines (mainly HeLa and MCF-7) present striking diversity across laboratories and that long-term continuous culturing results in genomic/transcriptomic heterogeneity with strong phenotypical implications. Here, we hypothesize that oligomutated pediatric sarcoma cell lines mainly driven by a fusion transcription factor, such as Ewing sarcoma (EwS), are genetically and phenotypically more stable than the previously investigated adult carcinoma cell lines. A comprehensive molecular and phenotypic characterization of multiple EwS cell line strains, together with a simultaneous analysis during 12 months of continuous cell culture show that fusion-driven pediatric sarcoma cell line strains are genomically more stable than adult carcinoma strains, display remarkably stable and homogenous transcriptomes, and exhibit uniform and stable drug response. Additionally, the analysis of multiple EwS cell lines subjected to long-term continuous culture reveals that variable degrees of genomic/transcriptomic/phenotypic changes among fusion-driven cell lines, further exemplifying that the potential for reproducibility of in vitro scientific results may be rather understood as a spectrum, even within the same tumor entity.

摘要

人类癌细胞系是癌症研究的支柱。最近的报告显示,高度突变的成人癌细胞系(主要是HeLa和MCF-7)在不同实验室之间存在显著差异,长期连续培养会导致基因组/转录组异质性,并产生强烈的表型影响。在此,我们假设主要由融合转录因子驱动的低突变儿童肉瘤细胞系,如尤因肉瘤(EwS),在遗传和表型上比先前研究的成人癌细胞系更稳定。对多个EwS细胞系菌株进行全面的分子和表型特征分析,并在连续12个月的细胞培养过程中同时进行分析,结果表明,融合驱动的儿童肉瘤细胞系菌株在基因组上比成人癌菌株更稳定,表现出显著稳定且均匀的转录组,并呈现出一致且稳定的药物反应。此外,对多个经过长期连续培养的EwS细胞系的分析表明,融合驱动的细胞系之间存在不同程度的基因组/转录组/表型变化,进一步说明即使在同一肿瘤实体中,体外科学结果的可重复性潜力也可能被理解为一个范围。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b7e/11699042/16e6070d5528/41467_2024_55340_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b7e/11699042/b835e833527b/41467_2024_55340_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b7e/11699042/16e6070d5528/41467_2024_55340_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b7e/11699042/b835e833527b/41467_2024_55340_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b7e/11699042/16e6070d5528/41467_2024_55340_Fig2_HTML.jpg

相似文献

1
Genomic and phenotypic stability of fusion-driven pediatric sarcoma cell lines.融合驱动的儿童肉瘤细胞系的基因组和表型稳定性
Nat Commun. 2025 Jan 3;16(1):380. doi: 10.1038/s41467-024-55340-5.
2
Single-cell transcriptional profiling reveals heterogeneity and developmental trajectories of Ewing sarcoma.单细胞转录组谱分析揭示尤因肉瘤的异质性和发育轨迹。
J Cancer Res Clin Oncol. 2022 Dec;148(12):3267-3280. doi: 10.1007/s00432-022-04073-3. Epub 2022 Jun 17.
3
Subversion of mRNA degradation pathways by EWSR1::FLI1 represents a therapeutic vulnerability in Ewing sarcoma.EWSR1::FLI1对mRNA降解途径的破坏是尤因肉瘤的一个治疗弱点。
Nat Commun. 2025 Jul 16;16(1):6537. doi: 10.1038/s41467-025-61725-x.
4
Ewing sarcoma depends on C4orf48/NICOL, a NELL2 cofactor regulated by Hippo signaling.尤因肉瘤依赖于C4orf48/NICOL,一种由Hippo信号通路调控的NELL2辅因子。
Cell Signal. 2025 Oct;134:111904. doi: 10.1016/j.cellsig.2025.111904. Epub 2025 May 30.
5
Simultaneous inhibition of mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways augment the sensitivity to actinomycin D in Ewing sarcoma.丝裂原活化蛋白激酶和磷脂酰肌醇3-激酶途径的同时抑制增强了尤因肉瘤对放线菌素D的敏感性。
J Cancer Res Clin Oncol. 2009 Aug;135(8):1125-36. doi: 10.1007/s00432-009-0554-z. Epub 2009 Feb 10.
6
Pharmacological targeting of P300/CBP reveals EWS::FLI1-mediated senescence evasion in Ewing sarcoma.靶向 P300/CBP 的药理学作用揭示了 EWS::FLI1 介导的尤文肉瘤中的衰老逃逸。
Mol Cancer. 2024 Oct 5;23(1):222. doi: 10.1186/s12943-024-02115-7.
7
Histone Deacetylase Inhibitors Target DNA Replication Regulators and Replication Stress in Ewing Sarcoma Cells.组蛋白去乙酰化酶抑制剂靶向尤因肉瘤细胞中的DNA复制调节因子和复制应激。
Cancer Res Commun. 2025 Jun 1;5(6):1034-1048. doi: 10.1158/2767-9764.CRC-25-0058.
8
Can a Liquid Biopsy Detect Circulating Tumor DNA With Low-passage Whole-genome Sequencing in Patients With a Sarcoma? A Pilot Evaluation.液体活检能否通过低深度全基因组测序检测肉瘤患者的循环肿瘤DNA?一项初步评估。
Clin Orthop Relat Res. 2025 Jan 1;483(1):39-48. doi: 10.1097/CORR.0000000000003161. Epub 2024 Jun 21.
9
Microsatellite instability in Ewing tumor is not associated with loss of mismatch repair protein expression.尤因肉瘤中的微卫星不稳定性与错配修复蛋白表达缺失无关。
J Cancer Res Clin Oncol. 2007 Oct;133(10):749-59. doi: 10.1007/s00432-007-0220-2. Epub 2007 May 25.
10
High-throughput RNAi screen in Ewing sarcoma cells identifies leucine rich repeats and WD repeat domain containing 1 (LRWD1) as a regulator of EWS-FLI1 driven cell viability.尤因肉瘤细胞中的高通量RNA干扰筛选确定富含亮氨酸重复序列和WD重复结构域1(LRWD1)是EWS-FLI1驱动的细胞活力的调节因子。
Gene. 2017 Jan 5;596:137-146. doi: 10.1016/j.gene.2016.10.021. Epub 2016 Oct 17.

引用本文的文献

1
Establishment of patient-derived 3D in vitro models of sarcomas: literature review and guidelines on behalf of the FORTRESS working group.肉瘤患者来源的3D体外模型的建立:代表FORTRESS工作组的文献综述与指南
Neoplasia. 2025 Jul;65:101171. doi: 10.1016/j.neo.2025.101171. Epub 2025 May 3.

本文引用的文献

1
Systematic multi-omics cell line profiling uncovers principles of Ewing sarcoma fusion oncogene-mediated gene regulation.系统的多组学细胞系分析揭示了尤文肉瘤融合癌基因介导的基因调控原则。
Cell Rep. 2022 Dec 6;41(10):111761. doi: 10.1016/j.celrep.2022.111761.
2
Pan-cancer proteomic map of 949 human cell lines.949 个人类细胞系的泛癌症蛋白质组图谱。
Cancer Cell. 2022 Aug 8;40(8):835-849.e8. doi: 10.1016/j.ccell.2022.06.010. Epub 2022 Jul 14.
3
First phase 1 clinical study of olaparib in pediatric patients with refractory solid tumors.
奥拉帕利治疗耐药性实体瘤儿科患者的首次 1 期临床研究。
Cancer. 2022 Aug 1;128(15):2949-2957. doi: 10.1002/cncr.34270. Epub 2022 May 20.
4
Drug Screening by Resazurin Colorimetry in Ewing Sarcoma.Resazurin 比色法在尤文肉瘤中的药物筛选。
Methods Mol Biol. 2021;2226:159-166. doi: 10.1007/978-1-0716-1020-6_12.
5
Oncogenic hijacking of a developmental transcription factor evokes vulnerability toward oxidative stress in Ewing sarcoma.致癌基因劫持发育转录因子导致尤文肉瘤对氧化应激敏感。
Nat Commun. 2020 May 15;11(1):2423. doi: 10.1038/s41467-020-16244-2.
6
Pan-cancer analysis of whole genomes.泛癌症全基因组分析。
Nature. 2020 Feb;578(7793):82-93. doi: 10.1038/s41586-020-1969-6. Epub 2020 Feb 5.
7
Multi-omic measurements of heterogeneity in HeLa cells across laboratories.多组学测量 HeLa 细胞在不同实验室间的异质性。
Nat Biotechnol. 2019 Mar;37(3):314-322. doi: 10.1038/s41587-019-0037-y. Epub 2019 Feb 18.
8
Genetic and transcriptional evolution alters cancer cell line drug response.遗传和转录进化改变癌细胞系的药物反应。
Nature. 2018 Aug;560(7718):325-330. doi: 10.1038/s41586-018-0409-3. Epub 2018 Aug 8.
9
Ewing sarcoma.尤因肉瘤。
Nat Rev Dis Primers. 2018 Jul 5;4(1):5. doi: 10.1038/s41572-018-0003-x.
10
OTP: An automatized system for managing and processing NGS data.OTP:一个用于管理和处理 NGS 数据的自动化系统。
J Biotechnol. 2017 Nov 10;261:53-62. doi: 10.1016/j.jbiotec.2017.08.006. Epub 2017 Aug 10.